Hospitals are experiencing shortages of sterile water used to reconstitute certain medications for injection, according to a new  by the American Society of Health-System Pharmacists and University of Utah Drug Information Service, which includes strategies to help pharmacists and organizations mitigate these shortages. 鈥淲ithout a consistent supply of SW for injection, health care personnel need to decide between selecting other therapies as treatments or using a sterile liquid other than SW for injection despite a lack of definite information about the effects on drug stability and compatibility,鈥 the factsheet notes. 鈥淭he consequences of using a sterile liquid not listed in product labeling to reconstitute medication vials may include poor dissolution of the powder, precipitation, or deactivation of the active pharmaceutical ingredient before further dilution or administration.鈥 For more on the SW shortages, see the  and  drug shortage databases.

Related News Articles

Headline
The Government Accountability Office yesterday released a report calling for the Department of Health and Human Services to improve its efforts responding to鈥
Headline
President Trump April 9 announced that reciprocal tariffs that went into effect after midnight for certain nations will be paused for 90 days, while tariffs鈥
Headline
The Food and Drug Administration March 14 released a notice on a nationwide shortage of hemodialysis tubes expected to last through early fall. On Jan. 8, B.鈥
Headline
The AHA late Feb. 4 told the administration that its current and proposed tariffs on Canada, Mexico and China may jeopardize the availability of vital鈥
Headline
Baxter Jan. 28 announced that IV solutions production has been restarted on all manufacturing lines at its North Carolina site impacted by Hurricane Helene in鈥
Headline
Baxter notified customers on Jan. 22 that allocations for two sodium chloride IV solutions have been increased to 100%. According to Baxter, the products will鈥